5XS2.F · LexaGene Holdings Inc

-

Please sign in to comment on 5XS2.F

1 Comment

Admin

4 years ago

LexaGene Holdings Inc is currently in a long term downtrend where the price is trading 22.0% below its 200 day moving average.

From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.

LexaGene Holdings Inc's total revenue sank by nan% to $0 since the same quarter in the previous year.

Its net income has dropped by 17.8% to $-3M since the same quarter in the previous year.

Finally, its free cash flow fell by 74.6% to $-3M since the same quarter in the previous year.

Based on the above factors, LexaGene Holdings Inc gets an overall score of 1/5.

Exchange	F
CurrencyCode	EUR
ISIN	CA52886L1031
Sector	Healthcare
Industry	Medical Devices

Market Cap	11M
Target Price	None
Dividend Yield	0.0%
Beta	2.26
PE Ratio	None

ABOUT

LexaGene Holdings Inc

LexaGene Holdings Inc., a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets; and assay panels. Its automated pathogen detection platform is used at the site of sample collection, which offers unprecedented ease-of-use, sensitivity, and breadth of pathogen detection. LexaGene Holdings Inc. was incorporated in 2007 and is headquartered in Beverly, Massachusetts.

5XS2.F · LexaGene Holdings Inc

-

LexaGene Holdings Inc

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest LexaGene Holdings Inc using a moving average strategy